Abstract:ABSTRACT Borrelia burgdorferi, the agent of Lyme disease, is estimated to cause >400,000 annual infections in the United States. Serology is the primary laboratory method to support the diagnosis of Lyme disease, but current methods have intrinsic limitations that require alternative approaches or targets. We used a high-density peptide array that contains >90,000 short overlapping peptides to catalog immunoreactive linear epitopes from >60 primary antigens of B. burgdorferi . We then pursued a machine learning approach to identify immunoreactive peptide panels that provide optimal Lyme disease serodiagnosis and can differentiate antibody responses at various stages of disease. We examined 226 serum samples from the Lyme Biobank and the National Institutes of Health, which included sera from 110 individuals diagnosed with Lyme disease, 31 probable cases from symptomatic individuals, and 85 healthy controls. Cases were grouped based on disease stage and presentation and included individuals with early localized, early disseminated, and late Lyme disease. We identified a peptide panel originating from 14 different epitopes that differentiated cases versus controls, whereas another peptide panel built from 12 unique epitopes differentiated subjects with various disease manifestations. Our method demonstrated an improvement in B. burgdorferi antibody detection over the current two-tiered testing approach and confirmed the key diagnostic role of VlsE and FlaB antigens at all stages of Lyme disease. We also uncovered epitopes that triggered a temporal antibody response that was useful for differentiation of early and late disease. Our findings can be used to streamline serologic targets and improve antibody-based diagnosis of Lyme disease. IMPORTANCE Serology is the primary method of Lyme disease diagnosis, but this approach has limitations, particularly early in disease. Currently employed antibody detection assays can be improved by the identification of alternative immunodominant epitopes and the selection of optimal diagnostic targets. We employed high-density peptide arrays that enabled precise epitope mapping for a wide range of B. burgdorferi antigens. In combination with machine learning, this approach facilitated the selection of serologic targets early in disease and the identification of serological indicators associated with different manifestations of Lyme disease. This study provides insights into differential antibody responses during infection and outlines a new approach for improved serologic diagnosis of Lyme disease.

Lyme serology in non-endemic countries: Why do we request it and what do we find?

Serological Epidemiology Investigation of Lyme Disease in Zhejiang Province

Pediatric Lyme Disease in Northern Italy: An 18-Year Single-Center Case Series

Case presentation and management of Lyme disease patients: a 9-year retrospective analysis in France

Seroprevalence of Infection by Borrelia Species Responsible for Lyme Disease in the French Alps: Analysis of 27,360 Serology Tests, 2015–2020

Serological Assessment of Lyme borreliosis in Bulgaria: A Nationwide Study

Is There a Role for Dark Field Microscopy in the Diagnosis of Lyme Disease?A Narrative Review

Retrospective Analysis of Potential Lyme Disease Clinical Cases in Argentina

Retrospective validation of a rapid Lyme fluorescent immunoassay in differentiating Lyme arthritis from other musculoskeletal presentations in children in a Lyme-endemic region

Identification of reactive Borrelia burgdorferi peptides associated with Lyme disease

A Comparison of Lyme Disease Serologic Test Results From 4 Laboratories in Patients With Persistent Symptoms After Antibiotic Treatment

Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011

Bacteremic and Nonbacteremic Brucellosis in Children in Turkey

Comparative Evaluation of Commercial Test Kits Cleared for Use in Modified Two-Tiered Testing Algorithms for Serodiagnosis of Lyme Disease

Borrelia burgdorferi infections in children and adolescents in Switzerland – a seroprevalence study 2023/2024 (BOBUINCA)

Diagnostic patterns of serum inflammatory protein markers in children with Lyme neuroborreliosis

A systemic approach to identify non-abundant immunogenic proteins in Lyme disease pathogens

Significance of Detecting Serum Antibodies to Outer Surface Protein A of Lyme Disease Borreliae in PCR-Confirmed Blood Infections

Diagnosis of neuroborreliosis in the context of local seroprevalence: A chart review study and a methodological overview

Evaluating polymicrobial immune responses in patients suffering from tick-borne diseases

Comparative Analysis of Pediatric Patients with Different Involvements of Brucellosis